BioRem Enterprise Value Over E B I T D A from 2010 to 2024
| BRM Stock | CAD 3.01 0.02 0.67% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 5.0985402 | Current Value 3.18 | Quarterly Volatility 7.58202166 |
Check BioRem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioRem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 281.4 K, Total Revenue of 18.5 M or Gross Profit of 5.5 M, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 2.89. BioRem financial statements analysis is a perfect complement when working with BioRem Valuation or Volatility modules.
BioRem | Enterprise Value Over E B I T D A |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.